Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Monogram Technologies Inc. Director's Dealing 2024

Apr 26, 2024

33540_dirs_2024-04-26_2ee1707e-c12c-48ed-94ba-32729939175e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MONOGRAM ORTHOPAEDICS INC (MGRM)
CIK: 0001769759
Period of Report: 2024-04-24

Reporting Person: Knape Noel (Chief Financial Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-04-24 Stock Option $2.33 A 25000 Acquired 2024-04-24 Common Stock (25000) Direct

Footnotes

F1: The options were issued under the Company's 2019 Stock Option and Grant Plan.

F2: 25% of the shares of Common Stock underlying the options will vest on the 1-year anniversary of the date of grant, and the remaining 75% of such shares shall vest in 12 equal 6-month installments over the next six years, becoming fully vested on April 24, 2030 (provided that Mr. Knape continues to have a service relationship with the Company as of the date of each vesting described herein).